Increased Choline Intake for Child Cognitive Development During Pregnancy
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to examine cognitive and affective outcomes in the offspring of women supplemented with choline vs. control during pregnancy.
Who Is on the Research Team?
Barbara J Strupp, PhD
Principal Investigator
Cornell University
Are You a Good Fit for This Trial?
This trial is for healthy pregnant women carrying one baby, between 12-18 weeks along, with a pre-pregnancy BMI under 35. Participants must be aged 21-40, planning to stay in Ithaca, NY area and deliver at Cayuga Medical Center. Excluded are those with high omega-3 intake, substance use during pregnancy, non-approved supplement use, certain health conditions or medications affecting metabolism or child outcomes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a 550 mg choline supplement or a 25 mg placebo daily during the second and third trimesters of pregnancy
Follow-up
Participants' infants are monitored for cognitive and affective outcomes at ages 5, 7, 10, and 13 months
What Are the Treatments Tested in This Trial?
Interventions
- Choline
Choline is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cornell University
Lead Sponsor